SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-22-009848
Filing Date
2022-09-19
Accepted
2022-09-19 09:14:33
Documents
15
Period of Report
2022-09-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-8k_20220919.htm   iXBRL 8-K 35204
2 EX-99.1 apvo-ex991_6.htm EX-99 18778
3 GRAPHIC gvoui1xwrlv4000001.jpg GRAPHIC 7008
4 GRAPHIC gvoui1xwrlv4000002.jpg GRAPHIC 10930
  Complete submission text file 0000950123-22-009848.txt   212779

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA apvo-20220919.xsd EX-101.SCH 5629
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20220919_lab.xml EX-101.LAB 19329
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20220919_pre.xml EX-101.PRE 11516
9 EXTRACTED XBRL INSTANCE DOCUMENT apvo-8k_20220919_htm.xml XML 3537
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 221249659
SIC: 2834 Pharmaceutical Preparations